Some researchers trained the immune systems of leukemia patients to help keep them in remission. And other researchers found ...

UT Southwestern Medical Center researchers have discovered that increasing the levels of a protein called BACH2 makes ...

In mantle cell lymphoma (MCL), an aggressive form of B-cell non-Hodgkin lymphoma, TP53 mutations are known to affect patients’ prognosis—but questions remain. What does the heterogeneity of TP53 ...

A 25-year-old woman says a GP “laughed” at her when she suggested she might have cancer, but later discovered she had Hodgkin ...

For the next three months, Kelly said she was “back and forth” to her GP surgery a total of six times, with a series of medical professionals unable to diagnose her condition. Feeling frustrated, ...

A 25-year-old woman who said a GP “laughed” at her when she suggested she might have cancer later discovered she had Hodgkin ...

The University of Cincinnati Cancer Center’s Tom Cunningham has received a two-year, $150,000 grant from the Lung Cancer Research Foundation (LCRF) to test approaches to neutralize an enzyme complex ...

How do immune cells strike a balance, unleashing rapid attacks against pathogens or cancer, while avoiding damage to healthy cells? Research into an immune kill switch holds potential for controlling ...

Based on the topline results from the EPCORE® DLBCL-1 trial, AbbVie along with partner Genmab will engage global regulatory authorities to discuss next steps NORTH ...

The FDA has granted full approval to verdinexor tablets (Laverdia; Anivive Lifesciences) for the treatment of dogs with lymphoma. The approval gives veterinarians a promising new oral avenue for ...

Based on the topline results from the EPCORE ® DLBCL-1 trial, Genmab will engage global regulatory authorities to discuss ...

Cervical lymphadenopathy presents a shared anatomic challenge for clinicians, yet it serves as the divergent starting point ...